Orchestra BioMed Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-3.9M | $1.8M |
| FY2022 | — | $-6.9M | $19.8M |
| FY2023 | — | $68.0M | $30.6M |
| FY2024 | $15.0M | $33.0M | $22.3M |
| FY2025 | $15.0M | $53.6M | $34.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-3.9M | $1.8M |
| FY2022 | — | $-6.9M | $19.8M |
| FY2023 | — | $68.0M | $30.6M |
| FY2024 | $15.0M | $33.0M | $22.3M |
| FY2025 | $15.0M | $53.6M | $34.7M |